Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05734404 · ClinicalTrials.gov registry record

Longitudinal Study for Central Nervous System Vasculitis

A clinical trial of Vasculitis and CNS Vasculitis, sponsored by University of Pennsylvania.

Recruiting
Registry status
40
Enrollment target
6
Study locations

NCT05734404 is a study of Vasculitis and CNS Vasculitis that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 40 participants, below the 27,315-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05734404, a study of Vasculitis and CNS Vasculitis, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
40 participants
Enrollment target
6
Study locations

Study Summary

Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a research cohort to investigate the disease process, treatments, and patient outcomes in CNSV.

Study Locations (6)

Other

  • St. Joseph's Healthcare - Hamilton
  • University of Toronto/Sinai Health - Toronto

Minnesota

  • Mayo Clinic - Rochester

Ohio

  • Cleveland Clinic - Cleveland

Pennsylvania

  • University of Pennsylvania - Philadelphia

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-03-01
Est. Completion 2030-12-31

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05734404

The ClinicalTrials.gov registry entry for NCT05734404 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 27,315-participant average among 11 other Vasculitis trials with a reported enrollment target (100% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Vasculitis appearing as the primary indexed condition, and to 0 interventions.

NCT05734404 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Other, Minnesota, Ohio.

Frequently Asked Questions

What is clinical trial NCT05734404 about?

NCT05734404 is a clinical study titled "Longitudinal Study for Central Nervous System Vasculitis". Primary central nervous system vasculitis (CNSV) is a potentially fatal, single-organ vasculitis that often involves a spectrum of neurologic complications, including strokes, cognitive and speech impairment, visual loss, dementia, and encephalopathy. The purpose of this study is to establish a rese...

What is the current status of trial NCT05734404?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2023-03-01. Estimated completion is 2030-12-31.

What conditions does trial NCT05734404 study?

This clinical trial studies the following conditions: Vasculitis, CNS Vasculitis, Central Nervous System Vasculitis, CNSV.

Who is sponsoring clinical trial NCT05734404?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05734404 being conducted?

This trial has 6 study locations across Minnesota, Ohio, Pennsylvania, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vasculitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.